About
Paclitaxel is a potent antineoplastic agent classified within the taxane family of chemotherapy drugs, widely utilized for its efficacy against a diverse range of solid tumors. Its unique mechanism of action involves binding to the beta-tubulin subunit of microtubules, promoting their assembly from tubulin dimers and simultaneously stabilizing them. This stabilization prevents the normal dynamic depolymerization of microtubules, which is a critical process for cellular functions such as cell division (mitosis), intracellular transport, and maintaining cell shape. By disrupting the dynamic equilibrium of the microtubule network, paclitaxel effectively arrests cancer cells in the G2/M phase of the cell cycle, ultimately triggering programmed cell death (apoptosis). This cytotoxic effect makes paclitaxel a cornerstone in the treatment regimens for cancers such as ovarian, breast, non-small cell lung cancer, and Kaposi's sarcoma.
Uses
- Treatment of ovarian cancer.
- Management of breast cancer.
- Non-small cell lung cancer (NSCLC) therapy.
- Treatment of Kaposi's sarcoma.
Directions For Use
This injection is administered intravenously by a healthcare professional, typically over several hours, as part of a chemotherapy regimen.
Benefits
- Broad-spectrum anti-cancer activity.
- Effective against various solid tumors.
- Can be used as first-line or subsequent therapy.
- Improves survival rates in many cancers.
- Often used in combination with other agents.
- Well-established efficacy profile.
Side Effects
- Myelosuppression (low blood counts)
- Peripheral neuropathy
- Hypersensitivity reactions
- Alopecia (hair loss)
- Nausea and vomiting
- Diarrhea
- Myalgia/arthralgia
- Fatigue
- Mucositis
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Liver enzyme elevation
Safety Measures
- Alcohol - Avoid alcohol during treatment as it may exacerbate side effects like nausea, fatigue, and liver strain.
- Pregnancy - Paclitaxel is contraindicated in pregnancy due to its genotoxic and teratogenic potential. Effective contraception is required for both male and female patients.
- Breastfeeding - Breastfeeding is contraindicated during paclitaxel treatment as the drug is likely excreted in human milk and could cause serious adverse reactions in the infant.
- Liver - Use with extreme caution in patients with severe hepatic impairment. Dose reductions are often necessary, and liver function should be closely monitored.
- Kidney - Use with caution in patients with severe renal impairment. No specific dose adjustment is usually required, but monitor for adverse effects.
- Lung - Rare cases of interstitial pneumonitis, pulmonary fibrosis, and radiation pneumonitis (in combination with radiation) have been reported. Monitor for respiratory symptoms.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!